drugset
drugset / Trial / NCT00004418

Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy

NCT00004418 ↗

Phase 2 Terminated 126 enrolled Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
NaSingle-groupOpen-labelTreatment

Summary

OBJECTIVES: I. Evaluate the clinical efficacy of combination glyceryl trierucate and glyceryl trioleate (Lorenzo's Oil) therapy in boys with X-linked adrenoleukodystrophy. II. Compare the frequency and severity of neurological disability of study patients with untreated historical controls.

Timeline

Start
1998-04
Primary completion
2014-12
Completion
2014-12

Outcome

Outcome not reported

Stopped (Business): “No funding, move to expanded access”

Drugs

EvaluationDrugModalityDoseRoute
Subject glyceryl trierucate/glyceryl trioleate Unknown — Oral

Indications

adrenoleukodystrophy